A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.

Clinical trial NCT00671216 · COMPLETED

Trial details

NCT number: NCT00671216
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2008-05-20
Primary completion: 2008-07-07
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.